Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An International, Multicentre, Double-blind, Randomised Study of the Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis Patients as Assessed by Magnetic Resonance Imaging

Trial Profile

An International, Multicentre, Double-blind, Randomised Study of the Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis Patients as Assessed by Magnetic Resonance Imaging

Status: Completed
Phase of Trial: Phase III/IV

Latest Information Update: 04 Dec 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Diacerein (Primary) ; Celecoxib
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Acronyms DISSCO
  • Sponsors TRB Chemedica

Most Recent Events

  • 22 Aug 2020 Results of this post-hoc analysis exploring the influence of patient age on the extent of response to treatment with diacerein presented at the 2020 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
  • 10 Jun 2020 Status changed from active, no longer recruiting to completed according to results published in the Rheumatology.
  • 10 Jun 2020 Results published in the Rheumatology

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top